This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chung, P. Articles by Evans, M. E. Search for Related Content PubMed PubMed Citation Articles by Chung, P. Articles by Evans, M. E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2006, p. 2957-2965, Vol. 50, No. 9
0066-4804/06/$08.00+0     doi:10.1128/AAC.00736-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Mechanism-Based Pharmacodynamic Models of Fluoroquinolone Resistance in Staphylococcus aureus

Department of Pharmaceutical Sciences, College of Pharmacy,¹ Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, University of Kentucky,² Division of Infectious Diseases, Department of Internal Medicine, Veterans Affairs Medical Center, Lexington, Kentucky³

Received 9 June 2005/ Returned for modification 17 September 2005/ Accepted 23 June 2006

Pharmacodynamic modeling from earlier experiments in which two ciprofloxacin-susceptible Staphylococcus aureus strains and their corresponding resistant grlA mutants were exposed to a series of ciprofloxacin (J. J. Campion, P. J. McNamara, and M. E. Evans, Antimicrob. Agents Chemother. 49:209-219, 2005) and levofloxacin (J. J. Campion et al., Antimicrob. Agents Chemother. 49:2189-2199, 2005) pharmacokinetic profiles in an in vitro system indicated that the subpopulation-specific estimated maximal killing rate constants were similar for both agents, suggesting a common mechanism of action. We propose two novel pharmacodynamic models that assign mechanisms of action to fluoroquinolones (growth inhibition or death stimulation) and compare the abilities of these models and two other maximum effect models (net effect and MIC based) to describe and predict the changes in the population dynamics observed during our previous in vitro system experiments with ciprofloxacin. A high correlation between predicted and observed viable counts was observed for all models, but the best fits, as assessed by diagnostic tests, and the most precise parameter estimates were obtained with the growth inhibition and net effect models. All models, except the death stimulation model, correctly predicted that resistant subpopulations would not emerge when a high-density culture was exposed to a high initial concentration designed to rapidly eradicate low-level-resistant grlA mutants. Additional experiments are necessary to elucidate which of the proposed mechanistic models best characterizes the antibacterial effects of fluoroquinolone antimicrobial agents.

This article has been cited by other articles:

• Venisse, N., Gregoire, N., Marliat, M., Couet, W. (2008). Mechanism-Based Pharmacokinetic-Pharmacodynamic Models of In Vitro Fungistatic and Fungicidal Effects against Candida albicans. Antimicrob. Agents Chemother. 52: 937-943 [Abstract] [Full Text]